Frequently Asked Questions


Show All
Where can I find all of RVL Pharmaceuticals’ regulatory filings, including quarterly and annual reports?
Quarterly and annual reports, as well as other regulatory filings, can be accessed on the SEC Filings section of our website or on the SEC’s website: www.sec.gov.
When does RVL Pharmaceuticals’ fiscal year end?
Our fiscal year ends December 31.
Does RVL Pharmaceuticals pay cash dividends?
We do not expect to declare or pay any cash or other dividends on our common stock, as we intend to reinvest cash flow generated by operations in our business.
Who are the company’s independent registered public accountants?
Ernst & Young
Who is the company’s transfer agent?
Our transfer agent is Computershare. They can be reached at:

Computer Share Investor Services
P.O. Box 505000
Louisville, KY 40233-5000
1- 877-373-6374 (US, Canada, Puerto Rico)
1- 781-575-3100 (non-US)

By overnight delivery:
462 South 4th Street, Suite 1600
Louisville KY 40202

Email: web.queries@computershare.com

Shareholder Online Inquiries: https://www-us.computershare.com/investor/Contact
Who is the company’s outside legal counsel?
The company is represented by Ropes & Gray LLP.
When did RVL Pharmaceuticals become a publicly traded company?
Our company began listing on the NASDAQ Global Market on October 18, 2018.
How do I contact Investor Relations with a question or request?
You can contact RVL Pharmaceuticals Investor Relations via email at: IR@RVL.com. In addition, you can reach Investor Relations by calling 212-452-2793.
Where is RVL Pharmaceuticals’ US corporate headquarters?

RVL Pharmaceuticals is headquartered in 400 Crossing Boulevard, Bridgewater, NJ 08807. Our Ireland office is in 3 Dublin Landings, North Wall Quay, Dublin 1, D01 C4E0, Ireland.

How can I be added to RVL Pharmaceuticals’ mailing list?
You can sign up for e-mail alerts notifying you of press releases, SEC filings or corporate news and events by clicking here.